Issue link: https://www.e-digitaleditions.com/i/1509086
54 Pharmaceutical Technology ® Trends in Formulation 2023 eBook PharmTech.com CPHI Exhibitor PROFILES Contact details 1000 N West St., Suite 1200 Wilmington, DE 19801 +1·844·636·2672 marketing@bora-corp.com www.boracdmo.com Hall and Booth: 3D38 Bora Pharmaceuticals B ora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO). Our six state-of-the-art cGMP manufacturing facilities across Asia and North America deliver to more than 100 markets around the world. Our sites have the highest industry standards for quality, development, manufacturing, packaging, and analytical testing We specialize in complex oral solids, liquids, semi-solids, ophthalmics and nasal sprays for pharmaceutical Rx and OTC products. Bora can provide solutions from early phase clinical through to commercial manufacturing with full packaging and serialization capabilities. Our large-molecule offerings include cell-line development, formulation development, analytical services, and clinical manufacturing to support our partners. As a future-focused CDMO, we know better than most that our own success is shaped by our partners victories. That's why, when you choose Bora — we make success more certain by following Bora's 5Ps — Promises, Partnerships, Pride, People, and Progress. These five principles are Bora's Pledge to our customers. Major products/services being exhibited Oral Solid Dose, Biologics, Ophthalmics, Nasal, liquid and semi-solid forms Contact details Maximilianstraße 10, 68165 Mannheim, Germany +49 621 421 150 +49 621 421 160 galenIQ@beneo.com lozenges, oro-dispersible mini-tablets, effervescents, and cough syrups. BENEO is a division of the Südzucker Group, that employs more than 1000 people and has production units in Belgium, Chile, Germany and Italy. www.BENEO.com Beneo About galenIQ™ B ENEO GmbH is part of the Südzucker Group and a member of the International Pharmaceutical Excipients Council (IPEC). BENEO produces galenIQ™ (Isomalt Ph. Eur., BP, USP-NF, JP), which is a water-soluble filler and binder. Derived from sucrose, galenIQ™ has a sweetness and taste profile that is very similar to sucrose, and therefore, galenIQ™ is frequently used to improve the palatability of bitter-tasting active pharmaceutical ingredients (APIs) and plant extracts. galenIQ™ is available in different median particle sizes, morphologies, and solubilities, which makes it the optimal choice for the formulation of a broad variety of dosage forms, such as chewable tablets, compressed